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Bah humbug! Association between sending Christmas cards to 
trial participants and trial retention: randomised study within a 
trial conducted simultaneously across eight host trials
Elizabeth Coleman,1 Catherine Arundel,1 Laura Clark,1 Laura Doherty,1 Katie Gillies,2 Catherine 
Hewitt,1 Karen Innes,2 Adwoa Parker,1 David Torgerson,1 Shaun Treweek2
ABSTRACT
Objectives
To determine the effectiveness of sending Christmas 
cards to participants in randomised controlled trials 
to increase retention rate at follow-ups, and to explore 
the feasibility of doing a study within a trial (SWAT) 
across multiple host trials simultaneously.
Design
Randomised SWAT conducted simultaneously across 
eight host trials.
setting
Eight randomised controlled trials researching various 
areas including surgery and smoking cessation.
ParticiPants
3223 trial participants who were still due at least one 
follow-up from their host randomised controlled trial.
interventiOn
Participants were randomised (1:1, separately by each 
host trial) to either received a Christmas card in mid-
December 2019 or to not receive a card.
Main OutcOMe Measure
Proportion of participants completing their next 
follow-up (retention rate) within their host randomised 
controlled trial.
results
1469 participants (age 16-94 years; 70% (n=1033) 
female; 96% (813/847) white ethnicity) across 
the eight host randomised controlled trials were 
involved in the analysis (cut short owing to covid-19). 
No evidence was found of a difference in retention 
rate between the two arms for any of the host trials 
when analysed separately or when the results 
were combined (85.3% (639/749) for cards versus 
85.4% (615/720) for no card; odds ratio 0.96, 
95% confidence interval 0.71 to 1.29; P=0.77). 
No difference was observed when comparing just 
participants who were due a follow-up in the 30 days 
after receiving the card (odds ratio 0.96, 0.42 to 2.21). 
No evidence of a difference in time to complete the 
questionnaire was found (hazard ratio 1.01, 95% 
confidence interval 0.91 to 1.13; P=0.80). These 
results were robust to post hoc sensitivity analyses. 
The cost of this intervention was £0.76 (€0.91; $1.02) 
per participant, and it will have a carbon footprint of 
approximately 140 g CO
2
 equivalent per card. One 
benefit of this approach was the need to only submit 
one ethics application.
cOnclusiOns
Sending Christmas cards to participants in 
randomised controlled trials does not increase 
retention. Undertaking a SWAT within multiple 
randomised controlled trials at the same time is, 
however, possible. This approach should be used 
more often to build an evidence base to support 
selection of recruitment and retention strategies. 
Although no evidence of a boost to retention was 
found, embedding a SWAT in multiple host trials 







The Charles Dickens classic A Christmas Carol, never 
out of print since publication in 1843, describes how 
Scrooge is visited by ghosts of Christmas past, present, 
and future. The Ghost of Christmas Past explains that 
he wears a chain he forged in life, stating: “I made it 
link by link, and yard by yard; I girded it on of my own 
free will, and of my own free will I wore it.”
This ghost is not alone in carrying a chain. Trials too 
haul chains, often wearily. A few links for an unclear 
question, one more for a poorly worded information 
leaflet, another for the consent form, and too many to 
count for the outcomes. Link by link, trials wear the 
chains we forge for them in design. One consequence 
of this chain may be that participants find the 
demands of the trial too taxing and stop responding. 
This leaves us with poor retention—in the same way 
that old Ebenezer, with his miserly ways and lack of 
Christmas cheer, was left him a staff turnover problem. 
Poor retention is vexing because it can adversely affect 
study validity.1-3
To mitigate this problem, researchers implement 
strategies to try to improve retention, such as sending 
text messages or Christmas cards.1 3 4 Although Scrooge 
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WHAT IS ALREADY KNOWN ON THIS TOPIC
Poor retention is problematic in randomised controlled trials and can hamper the 
validity of trial results
Many retention strategies are used without evidence of their effectiveness
Evaluations of evidence based strategies are needed to ensure that the most 
effective strategies are being used to avoid research waste
WHAT THIS ADDS
In an adult UK population, Christmas cards are an ineffective retention strategy
Alternative retention methods should be used, and methods similar to this, such 
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is unlikely to have sent Christmas cards, many trial 
teams do. A 2017 survey of UK registered clinical 
trials units found that 40% had previously used 
Christmas cards as a retention strategy despite a lack 
of evidence supporting their use.4 The implementation 
of this strategy requires both money (for printing and 
posting) and staff time. This expense may be viewed as 
justifiable if evidence shows an increase in retention 
rates; otherwise it contributes to research waste, and 
trial teams should implement a strategy shown to 
work.
However, many, if not most, retention strategies have 
little robust evidence to guide their use. In the absence 
of high certainty evidence, one way of changing this 
situation would be to evaluate the effectiveness of 
retention strategies by embedding a study within a 
trial (SWAT) into the host trial, whereby participants 
are randomised to receive different strategies and the 
effect on retention is measured.5
As single SWAT evaluations are not usually powered 
to show a small difference in effectiveness, owing to 
their limited size, many replications of a SWAT are 
needed in different settings and populations to allow 
for a fair evaluation of effectiveness to be made.6 Thus, 
years may be needed for enough SWAT replications to 
be done to reach a conclusion on the intervention’s 
effectiveness. One way to speed up this process, and 
allow for rapid collection of evidence, would be to 
plan to do the same SWAT simultaneously in several 
host trials. The feasibility of conducting simultaneous 
SWATs of the same intervention has been investigated 
only a few times.7 8 This frugal, evidence based 
approach to retention strategy selection is one that 
Scrooge, we are sure, would approve of. Therefore, the 
aim of this study was to run a SWAT to evaluate the 
sending of Christmas cards as a trial retention strategy, 
across multiple host trials simultaneously.
Methods
Design
This SWAT was registered with the Northern Ireland 
Hub for Trial Methodology Research SWAT Repository 
(SWAT 82), and each of the host trials was registered 
individually (table 1).9 The two arm study was 
embedded within eight host UK randomised controlled 
trials simultaneously in December 2019, by two clinical 
trials units: York Trials Unit (YTU) and Aberdeen’s 
Centre for Healthcare Randomised Trials (CHaRT). 
We invited all host trials at the two coordinating units 
that were anticipated to be following up participants 
after Christmas 2019 to participate, and we assessed 
those wanting to participate for their suitability for 
this intervention (that is, in terms of trial population 
and follow-up method). Trials could continue to use 
any other retention strategies that were planned, as a 
benefit from these would be equally applicable to both 
arms of this SWAT. The eight host trials included in the 
evaluation (C-Gall, CPIT-3, DISC, FUTURE, ProFHER-2, 
PUrE, REFLECT, and SWHSI-2) span a wide range of 
research areas, including dental hygiene, surgery, and 
smoking cessation in pregnant women (table 1).10-17 
We planned a follow-up period of one year, to allow for 
each participant in the SWAT to have had at least one 
follow-up.
Protocol changes
Owing to the covid-19 pandemic, many trials had to alter 
the way in which they followed up their participants, 
including implementation of other retention strategies 
or switching from in-person follow-up to remote data 
collection, which could introduce more heterogeneity. 
Additionally, how participants’ retention behaviour 
may change because of the pandemic and what the 
future was for many of the trials were unknown. We 
(all authors of this paper) discussed this and decided 
that, to allow for a true evaluation of this intervention, 
we would stop the SWAT early and include only follow-
ups that were due on or before 31 March 2020 rather 
than mid-December 2020 (that is, to evaluate the effect 
on outcome data collection up to three months rather 
than the originally planned 12 months).
Participants and randomisation
This SWAT’s sample size was constrained by that 
of its host trials; therefore, we did no formal power 
calculation, as is standard practice for SWAT 
evaluations.2 5 In this evaluation, as the SWAT was 
done simultaneously in multiple host trials, the sample 
size was larger than is usual in a single SWAT.
We implemented this SWAT within all eight trials at 
the same time (December 2019), and any participants 
of the host trials who were still in follow-up, regardless 
of what time point they were at, were eligible to be 
No evidence was found to suggest that sending participants a 
Christmas card would encourage them to complete their next 
follow-up, or that they would complete it sooner
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included in the SWAT, as long as they had a postal 
address recorded. We gave some consideration as 
to whether inclusion of specific participants was 
appropriate, particularly in the pregnancy trial if a 
known negative outcome had occurred, and inclusion 
of participants was at the discretion of each of the 
individual trial teams.
As we and our ethics committee considered the 
SWAT to be low risk, and as all participants in the SWAT 
were to be blinded to their participation, we obtained 
no further consent from participants. Additionally, 
each host trial had consent from their participants to 
contact them regarding research, to use their data for 
research purposes, and to share their anonymised data 
for research. The host trials collected all data routinely, 
according to their protocols.
Randomisation was done separately for each host 
trial. The host trials being run by YTU each used 
randomisation which was stratified by host trial 
allocation, using blocks of varying size (all used four 
and six, and all bar SWHSI-2 also used two), to ensure 
balance as some of the trials to be included had a low 
sample size at the point of randomisation. Trials from 
CHaRT used simple randomisation. All schedules 
used a 1:1 ratio, and the randomisation was done by 
a person not involved in the preparing and sending of 
the cards.
intervention
The intervention to be tested within this SWAT 
evaluation was the sending of a Christmas card to 
participants in the host trials. The card selected 
table 1 | Descriptions of host trials





c-gall10 (cHart) A randomised controlled trial comparing 
laparoscopic cholecystectomy with 
observation/conservative management 
for preventing recurrent symptoms and 





Surgery: gallbladder Short Form-36 at 18 
months
Postal 430
cPit-311 (ytu) The smoking cessation in pregnancy 
incentives trial: A multi-centre 
phase 3 randomised controlled trial 
(ISRCTN15236311)
Both groups receive 
smoking cessation service 
support and contingent 
shopping vouchers. 
Intervention group receive 
additional shopping 
vouchers (up to £400)
Smoking in pregnancy Self-reported 
abstinence from 
smoking for 8 weeks
Telephone 940
Disc12 (ytu) A pragmatic multi-centre randomised 
controlled non-inferiority, cost 
effectiveness trial comparing injections 
of a collagenase into the cord to surgical 
correction in treatment of moderate 
Dupuytren’s contracture in adult patients 
(ISRCTN18254597)
Injection of collagenase or 
surgery
Surgery/drug: hand Patient evaluation 
measure at 1 year
Clinic/postal 710
Future13 (cHart) A superiority randomised clinical trial 
to evaluate the effectiveness and cost 
effectiveness of invasive urodynamic 
investigations in management of women 











Improvement at 15 
months
Postal 1096
ProFHer-214 (ytu) A three-arm randomised controlled trial 
to assess the effectiveness and cost-
effectiveness of reverse shoulder arthroplasty 
verses hemi-arthroplasty verses non-surgical 
care for acute three- and four-part fractures 





Surgery: shoulder Oxford Shoulder 
Score at 2 years
Clinic/postal 380
Pure14 (cHart) The clinical and cost effectiveness of surgical 
interventions for stones in the lower pole of 
the kidney (ISRCTN98970319)
Extracorporeal shockwave 
lithotripsy or percutaneous 
nephrolithotomy or flexible 
ureterorenoscopy with laser 
lithotripsy
Surgery: kidney EQ-5D-5L at 12 
weeks
Postal 1044
reFlect15 (cHart) A randomised controlled trial to evaluate the 
effectiveness and cost benefit of prescribing 
high dose fluoride toothpaste in preventing 
and treating dental caries in high-risk older 
adults (ISRCTN11992428)
Prescription of 5000 ppm 
fluoride toothpaste or 
usual care
Dental Proportion of 
participants receiving 
dental care due to 
caries at 36 months
Postal 1174
sWHsi-217 (ytu) A pragmatic multicentre randomised 
controlled trial to assess the clinical and 
cost effectiveness of negative pressure 
wound therapy versus usual care for surgical 
wound healing by secondary intention 
(ISRCTN26277546)
Negative pressure wound 
therapy or usual care 
(normal dressing)
Wound healing Time (days) to 
wound healing
Postal 696
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featured a snowy winter scene and had the words 
“Season’s Greetings” on the front (fig 1). All of the 
cards contained the same message: “Thank you for 
taking part in [TRIAL ACRONYM]. Wishing you a Merry 
Christmas and a Happy New Year. From the [TRIAL 
ACRONYM] Study Group.” However, this was tailored 
slightly to the specific host trial, by including the 
signature from the chief investigator, or local principal 
investigator for CPIT-3, the signatures of the trial office 
team for the CHaRT trials, and the study logo. The 
respective trial teams put the Christmas cards into 
envelopes while listening to Christmas classics (Mariah 
Carey is an Aberdeen favourite), ate mince pies, and 
generally had a jolly time. Each host trial posted cards 
to participants allocated to the SWAT intervention 
between 11 and 17 December 2019, depending on the 
host trial, as second class letters by Mailmark franking 
via Royal Mail, expected to arrive in two to three 
working days. The control group received no card, but 
all other follow-up processes remained as per the host 
trial protocol.
Outcomes
The primary outcome for this evaluation was the 
proportion of participants who completed their next 
follow-up (retention rate); we measured this as the 
number of completed follow-ups divided by the number 
of follow-ups that were due. When a participant had 
multiple follow-ups within the SWAT follow-up period, 
we included only the first one. Secondary outcomes 
were time to complete the follow-up (defined as 
number of days between follow-up due and follow-up 
complete), cost per card sent (including staff time and 
printing and postage costs), and cost per additional 
participant retained (if applicable)
We also explored the effect of the Christmas card on 
the subgroup of participants who were due to receive 
a follow-up shortly (up to 30 days) after the expected 
delivery date of the card. We theorised that if this 
intervention influenced retention, the effect would be 
most prevalent in participants who were due to have 
their follow-up shortly after receipt of the card, as those 
whose follow-up was due later may not remember 
receiving the card.
We also included a post hoc analysis to calculate CO
2
 
emissions of this Christmas card SWAT. Additionally, 
we ran post hoc sensitivity analyses to explore the 
effect of the baseline imbalance of sex on the primary 
outcome and time to completion for only postal follow-
ups, as a quicker response is applicable only in these 
follow-ups.
statistical analysis
We used Stata v.16 for all analyses, using the 
principles of intention to treat, whereby we analysed 
all participants according to the group to which they 
were randomised, regardless of whether they received 
the intervention. We used a 5% significance level and 
excluded participants from the analysis if they had 
been randomised in error or had withdrawn from 











































































































the bmj | BMJ 2021;375:e067742 | doi: 10.1136/bmj-2021-067742 5
follow-up before the posting of the card but had been 
randomised into the SWAT.
All analysis models were adjusted for the host 
trial allocation (that is, their control/intervention 
allocation from the respective main trial) and the SWAT 
allocation and were run for each host trial separately. 
No adjustment was made for baseline imbalance in 
the main analyses. We used a random effects meta-
analysis to combine the results of the individual 
trials. The primary analysis used a logistic regression 
model to compare the retention rate between the two 
arms. We analysed time to completion (days between 
follow-up due and follow-up complete) by using a 
Cox proportional hazards regression; participants 
who completed their follow-up on time or early had 
their time set to 0.1, those who did not complete it 
or completed it more than 90 days after the due date 
were censored at 90 days, and those who withdrew 
after their follow-up was due were censored at their 
withdrawal date. We used Schoenfeld residuals to 
assess the assumptions for this model.18
We did a subgroup analysis by rerunning the primary 
analysis model including only those participants 
whose follow-up was due within 30 days of the 
expected delivery date for the Christmas card for that 
trial. We did a sensitivity analysis in which the primary 
analysis model was rerun for each host trial with 
further adjustment for sex; we then also combined 
these results in a meta-analysis. In a second sensitivity 
analysis, the time to completion analysis was rerun 
including only participant follow-ups done by post 
(that is, excluding CPIT-3 completely and any clinic 
follow-ups from ProFHER-2 and DISC).
We present the results for each model fitted, with the 
reference group being participants in the intervention 
arm. We present the results according to CONSORT 
guidelines for randomised controlled trials, with 
appropriate adjustments where these do not apply to 
SWATs.
We calculated the average cost per card sent as the 
sum of the cost per card for preparation, postage, and 
printing of the card. As different numbers of cards were 
involved at each of the three stages, the cost per card 
for each element was calculated separately, to give the 
most accurate estimate for the respective element. We 
calculated the cost per card as the total of the cost for 
each element divided by the number of cards involved. 
We calculated this as an overall cost for the SWAT, rather 
than for each host trial, to give a better estimate of the 
true cost. We recorded staff time and grade for each 
member of staff involved in packaging the Christmas 
cards; we used the salary of the midpoint of the grade 
band for each member of staff, from their respective 
university (figures were obtained in November 2020). 
We calculated the associated cost for each member of 
staff by using the time they had spent preparing the 
cards (in hours) multiplied by their associated hourly 
pay. We set the cost of postage per card as the cost for 
second class Royal Mail using Mailmark franking in 
December 2019 and recorded the cost of printing from 
the printing order. We then summed these costs per 
card to provide a total cost per card. Should we find 
that the intervention was effective, we would divide 
the total cost by the number of additional participants 
retained, to give a cost per additional participant 
retained.
We based assumptions for the CO
2
 emissions 
calculation on previous research, assuming that the 
card weighs 10 g, is printed on recycled paper, and 
is posted and recycled in the UK.19 We included only 
cards printed and sent in this analysis.
Patient and public involvement
CHaRT has previously sent Christmas cards to trial 
participants, but not as part of an evaluation. We 
consulted a patient and public involvement (PPI) 
group consisting of six members from the Health 
Services Research Unit PPI Partnership on the design 
and content of the card in November 2019. The 
group reviewed two different card designs and the 
wording inside the card and were offered the chance 
to provide feedback on any other aspect. Most of the 
group members agreed on the card that was ultimately 
used in all host trials (fig 1) and deemed the card to be 
acceptable.
Results
A total of 3223 participants were randomised to be 
included in this SWAT—1617 to receive the Christmas 
card and 1606 to not receive a card (table 2). We 
excluded three participants who had no contact address 
recorded and so were not eligible to be included in the 
table 2 | baseline characteristics of participants included in primary analysis (due for follow-up on/before 31 March 2020), by arm, for each host trial and 
overall. values are numbers (percentages) unless stated otherwise
trial
intervention—participants allocated to receive card control—participants allocated not to receive card
randomised* analysed
Mean (sD; range) age, 
years Female sex White ethnicity randomised* analysed
Mean (sD; range)  
age, years Female sex White ethnicity
C-Gall 205 110 (54) 50.3 (15.1; 21-80) 86 (78) 96 (87) 197 108 (55) 48.5 (14.8; 19-80) 86 (80) 92 (85)
CPIT-3 242 157 (65) 28.4 (5.7; 16.8-43.0) 157 (100) 155 (99) 242 155 (64) 27.4 (5.7; 16.8-41.9) 155 (100) 155 (100)
DISC 205 125 (61) 67.5 (8.7; 31.4-84.8) 22 (18) 125 (100) 203 117 (58) 67.7 (8.5; 39.2-89.2) 28 (24) 117 (100)
FUTURE 273 155 (57) 60.8 (12.8; 23.1-82.3) 155 (100) - 270 138 (51) 63.3 (13.2; 25.3-94.4) 138 (100) -
ProFHER-2 45 17 (38) 77.4 (6.8; 65.5-87.6) 13 (76) 17 (100) 47 15 (33) 75.2 (5.2; 68.8-87.0) 13 (87) 13 (87)
PurE 75 20 (27) 58.2 (14.4; 29.3-82.1) 8 (40) - 74 27 (36) 53.1 (12.5; 27.9-75.8) 14 (52) -
REFLECT 546 144 (26) 65.0 (8.5; 50.1-85.7) 78 (54) - 547 138 (25) 64.0 (8.7; 50.6-87.8) 70 (51) -
SWHSI-2 26 21 (81) 61.3 (7.8; 49.2-75.6) 3 (14) 21 (100) 26 22 (85) 59.5 (13.3; 30.7-80.1) 7 (32) 22 (100)
Overall 1617 749 (46.3) 54.7 (18.0; 16.8-87.6) 522 (69.7) 414/430 (96) 1606 720 (44.8) 53.9 (18.5; 16.8-94.4) 511 (71.0) 399/417 (96)
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SWAT. Additionally, one participant was randomised 
three times in error; we included the first allocation 
in the analysis and excluded the other two allocations 
(one in each arm). At least one card was returned as 
the participant no longer lived at the stated address; 
however, they are included in the analysis under the 
intention to treat principle.
Only 1469 (749 randomised to receive the card; 720 
not) participants were due a follow-up on or before 
31 March 2020 and thus are included in the analysis 
(45.6% of 3223 randomised) (table 2). The percentage 
of randomised participants included in the analysis 
varied from 26% (282/1093, REFLECT) to 83% (43/52, 
SWHSI-2), as shown in table 2; this was due to both the 
frequency of the follow-ups and the stage the trial was 
at. For instance, the participants in SWHSI-2 were due 
their three month and six month follow-ups, whereas 
those in REFLECT were due their one year follow-up. 
Figure 2 shows the flow of participants through the 
SWAT. Table 2 shows the baseline characteristics of the 
Host trials interested
Participants allocated to receive a card
Excluded
Randomised in error
    CPIT-3
No address found
    ProFHER-2
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participants included in the analysis. Most participants 
were female (1033/1469; 70%) and of white ethnicity 
(813/847; 96%). Additionally, as shown table 1, most 
of the trials implemented postal follow-up, which may 
not be typical of all trials.
Primary outcome
The overall rate of completion of the next follow-up 
(retention rate), for all trials combined, was 85.4% 
(1254/1469 follow-ups completed); this ranged from 
63% (27/43) to 96% (280/293) for overall completion 
per host trial (table 3). We observed similar levels of 
retention in the two arms overall—85.3% (639/749) 
for participants who received the Christmas card and 
85.4% (615/720) for those who did not. The retention 
rate seen in most of these trials is in line with the 
median retention of 89% for a cohort of publicly funded 
UK trials as reported by Walter et al.20 The trials with 
lower retention rates (PUrE and SWHIS-2, as shown in 
table 3) have low sample sizes, so this may not reflect 
the retention of the trial once completed. We found no 
evidence of a difference in retention rate between the 
two arms for all eight of the host trials when analysed 
separately (table 3).
When we combined the results by using a random 
effects meta-analysis, we found no evidence of a 
difference in the retention rates between participants 
who received a Christmas card and those who did not 
(odds ratio 0.96, 95% confidence interval 0.71 to 1.29; 
P=0.77). Figure 3 shows a cumulative meta-analysis.
secondary outcomes
Follow-up due within 30 days
Only 20.8% (305/1469) of the participants in this 
SWAT evaluation were due a follow-up shortly after 
the delivery of the Christmas card. Of the 305 follow-
ups included in this subgroup, 263 were completed—a 
retention rate of 86%, similar to that seen for all 
participants. This was similar between the two arms—
85% for those who received a Christmas card (135/158) 
and 87% (128/147) for those who did not. Most of the 
trials had too few participants for the results of any 
analysis to be reliable, so we fitted a model only for 
CPIT-3 and DISC. FUTURE had enough participants for 
the model to be run, but all participants in the control 
group completed the follow-up, so an estimate cannot 
be obtained. Neither DISC nor CPIT-3 showed any 
evidence of a difference in retention rate between the 
two arms, considering just participants who were due 
a follow-up shortly after the delivery of the Christmas 
card (odds ratio 0.76, 0.24 to 2.39 (P=0.64) for DISC; 
1.24, 0.37 to 4.23 (P=0.73) for CPIT-3). Combining 
these results in a meta-analysis gives an odds ratio of 
0.96 (0.42 to 2.21). This result mirrors that found in 
the primary analysis; participants who were sent a card 
were less likely to complete their follow-up, although 
the result is not significant.
Time to complete
On average, the follow-ups were completed 26.3 days 
after they were due; this was similar between the two 
arms (26.1 days for those who received a card and 
26.4 for those who did not). The average time varied 
widely between the trials involved, most likely because 
of the method of follow-up (supplementary table A). 
For instance, CPIT-3 had no follow-ups that were 
completed early; the follow-up for this trial was done 
by a researcher telephoning a participant, so it could 
not be completed early. In some of the surgical trials, 
such as DISC, the follow-up may have been completed 
during a clinical follow-up appointment, which may 
have been scheduled early in a specified visit window 
for the participant’s convenience. For each of the 
host trials, we found no evidence of a difference in 
time to complete the follow-up between the two arms 
(supplementary table A), and the assumptions of 
proportional hazards held for each trial. The overall 
meta-analysis also supported the conclusion that no 
evidence exists of a difference between the two arms 
(hazard ratio 1.01, 95% confidence interval 0.91 to 
1.13; P=0.80) (supplementary table A). Figure 4 shows 
a cumulative meta-analysis.
Cost per card
The costs below are detailed for the overall SWAT, 
including all Christmas cards that were sent (n=1617). 
A surplus of cards was ordered (n=1787), and owing 
to the way in which printing was done, an additional 
surplus was received and subsequently prepared 
in some instances. Preparing and packaging 1836 
Christmas cards took 918 minutes (15.3 hours)—
approximately 30 seconds per card. The members of 
staff involved with the preparation ranged from a grade 
3 to a grade 7, with pay ranging from approximately 
table 3 | completion rates of follow-ups, details of primary outcome for each host trial, and combined meta-analysis results. values are percentages 
(numbers completed/numbers due) unless stated otherwise
trial sent a card not sent a card Overall adjusted odds ratio (95% ci)* P value
C-Gall 87 (96/110) 86 (93/108) 87 (189/218) 1.08 (0.49 to 2.37) 0.84
CPIT-3 90 (142/157) 90 (139/155) 90 (281/312) 1.09 (0.52 to 2.30) 0.81
DISC 84 (105/125) 87 (102/117) 86 (207/242) 0.77 (0.37 to 1.58) 0.47
FUTURE 95 (147/155) 96 (133/138) 96 (280/293) 0.66 (0.21 to 2.08) 0.48
ProFHER-2 82 (14/17) 80 (12/15) 81 (26/32) 1.05 (0.16 to 6.76) 0.96
PurE 65 (13/20) 70 (19/27) 68 (32/47) 0.88 (0.25 to 3.11) 0.84
REFLECT 75 (108/144) 75 (104/138) 75 (212/282) 0.97 (0.57 to 1.67) 0.92
SWHSI-2 67 (14/21) 59 (13/22) 63 (27/43) 1.38 (0.40 to 4.79) 0.61
Overall 85.3 (639/749) 85.4 (615/720) 85.4 (1254/1469) 0.96 (0.71 to 1.29) 0.77
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£11.01 to £22.46 per hour. Each card was posted by 
second class Royal Mail using Mailmark franking at 
a cost of £0.41 each. Thus, the total cost of sending 
the Christmas cards was £1306.40 or £0.76 (€0.91; 
$1.02) per card sent. As we found no evidence of 
additional participants being retained, we did not 
calculate a cost per additional retained participant. 




The estimate for the “carbon footprint” of a typical 
greetings card, such as a Christmas card, is 140 g 
CO
2
 equivalent.19 Based on the 1617 cards sent to 
participants in the intervention arm, the average 
amount of CO
2
 produced in this SWAT was 226 kg. 
This is equivalent to a return flight from Aberdeen 
to Leeds (York’s closest airport—approximately 230 
miles direct distance). Based on previous research 
that identified 40% of clinical trials units having used 
Christmas cards as a retention strategy previously, and 
assuming that each UK clinical trials unit (n=53 UKCRC 
registered) would send cards in 10 host trials, each of 
moderate size (n=250), this would equate to a total CO
2
 
emission of 4.5 tonnes per year.4 This does not account 
for additional trials that use Christmas cards but are 
conducted outside a registered clinical trials unit.
sensitivity analyses
Our sensitivity analyses looking at sex and postal-only 
time to completion confirmed our original conclusions. 
More details are in the supplementary materials.
Discussion
In this study, we investigated the effect of sending a 
Christmas card to trial participants to boost retention. 
Although covid-19 shortened the follow-up period and 
limited the sample size, the data from more than 1400 
participants across eight parallel evaluations show 
that sending a Christmas card to trial participants did 
not increase the retention rate, either in general or for 
participants who are due a follow-up within 30 days 
of receiving the card. Sending a Christmas card also 
did not influence the time taken for participants to 
complete the follow-up.
The intervention evaluated here may be one that trial 
teams favour, as it is relatively cheap to implement. 
However, other interventions exist that are cheap and 
show some benefit. For example, the effect estimate for 
including a pen with a trial questionnaire is a 2% (95% 
confidence interval 0% to 4%) increase in retention.3
Although we have concluded that sending 
Christmas cards does not result in a retention benefit 
for trials, whether it may have other benefits is worth 
considering. For instance, thanking/acknowledging 
participants’ time may be considered good manners, 
which may be worth the minor cost. However, this 
may be better suited to a “Thank you” card, which 
could offer an opportunity to provide text targeting 
things known to influence trial retention. Efforts to 
recruit and retain more diverse trial populations also 
point in the direction of alternative interventions with 
wide applicability and evidence of benefit. Finally, as 
sending Christmas cards is associated with a carbon 
cost, using scheduled opportunities to say thank you, 
such as questionnaire cover letters (see, for example, 
Goulao et al 21), may be wiser.
Overall, the retention rate in the eight host trials 
was in line with typical median retention rates of 89% 
seen in publicly funded UK randomised controlled 
trials.20 Perhaps a greater effect would be seen in trials 
with much lower retention of, say, 60%. Although we 
found no evidence of a difference in retention for this 
intervention, we acknowledge that any intervention 
that boosts retention is useful, as many small increases 
will accumulate and lead to a significant increase, 
which could ultimately influence the strength of the 
host trials’ findings.
This study showed that a single SWAT can be 
embedded successfully by multiple host trials across 
multiple clinical trials units simultaneously. This not 
only increases the speed at which evidence can be 
accumulated but has the additional benefit of allowing 
only one ethics application to be submitted to cover all 
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strengths and limitations of study
When we initially planned this simultaneous SWAT, 
we hoped to involve more than 10 trials and more than 
10 000 participants to ensure that the question could 
be answered by this one evaluation. The evaluation 
was delayed for various reasons, and some host trials 
could no longer embed the SWAT, which reduced the 
sample size. Additionally, although more than 3000 
participants were randomised into this trial, the 
covid-19 pandemic meant that follow-up had to be 
cut short and as a result the sample size was reduced 
further. Moreover, we requested demographic data 
only for host trial participants due for follow-up by 31 
March 2020 to reduce the burden on host trial teams 
during a difficult year. This means that we are unable to 
say whether our group of participants is different from 
those who would have been followed up after March 
2020. Despite this, the lack of any clear evidence of 
benefit seen in our evaluation makes us confident that 
had the SWAT run for the entire year we would still 
have reached the same conclusion; if there was benefit 
to be had, it would be most apparent for participants 
being followed up close to Christmas. That effects get 
greater the further from Christmas follow-up occurs 
seems improbable.
This SWAT was successfully implemented across 
eight host trials, from two clinical trials units in the UK, 
at the same time. This is one of the first instances in 
which a SWAT evaluation has been undertaken in this 
way, and its success should influence other researchers 
to consider doing simultaneous SWATs in the future, 
to allow answers to the methodological questions that 
SWATs pose to be obtained more quickly.
Future research
This trial was conducted in a wide variety of randomised 
controlled trials and associated participants, and no 
evidence of an effect was apparent. Thus, in line with 
Trial Forge Guidance 2,6 we consider that this question 
is answered, for UK adults at least, and recommend 
that future SWATs should prioritise the evaluation of 
other retention strategies, using a simultaneous design 
if possible.
However, consideration should be given to whether 
a future evaluation of this intervention in children and/
or teenagers, or in those trials in which trial-participant 
relationships are more important, such as cancer 
trials, may lead to a different result. Additionally, 
this evaluation specifically focused on a Christmas 
card, which the PPI Group deemed appropriate for the 
populations in the associated host trials. Trial teams 
should consider evaluations of other cards, such as 
birthday or thank you cards, as well as exploring the 
effect of other culturally appropriate cards within 
different ethnic populations.
As we have concluded that this SWAT evaluation 
design is feasible and efficient, it should be used in 
future research. This design could be used to assess 
both recruitment and retention SWATs, as well as other 
methodological aspects such as protocol/treatment 
compliance strategies, and is suitable in most, if not 
all, research fields.
conclusion
“Bah humbug!” is the appropriate evidence based 
response to any colleague who suggests sending 
Christmas cards as a trial retention strategy to an 
adult population. Instead, trial teams should turn 
to strategies that have evidence of benefit, or where 
evidence is lacking trial teams should build SWATs into 
their trials to generate that evidence.
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table 4 | Details of cost associated with christmas cards
task total cost (£)* no of cards involved cost per card sent (£)*
Preparing cards 209.91 1836 0.11
Postage 662.97 1617 0.41
Printing and delivery 433.52 1787 0.24
Overall 1306.40 - 0.76
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Dissemination to participants and related patient and public 
communities: Despite the danger of being seen as the team 
that cancelled Christmas cheer in trials, we intend to disseminate 
these results widely through presentations at the PROMETHEUS 
hosted webinar series (https://www.york.ac.uk/healthsciences/
research/trials/research/swats/prometheus/), via the international 
Trial Forge SWAT Network (https://www.trialforge.org/2021/06/
swat_network/), and on the PROMETHEUS website (https://www.york.
ac.uk/healthsciences/research/trials/research/swats/prometheus/). 
Additionally, the results will be presented at relevant conferences in 
the usual way and on social media in less usual ways.
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